ZXK-22238-06719
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 494 / MI
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-29
- 2021-02-04
-
2021-02-10
Dose 2 — Pfizer-BioNTech
- 2021-02-25
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-03-24
-
2021-05-12
Survey response — 3 months, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Excessive bleeding during period.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-03
- 2021-08-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-10 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-12 | Unsuccessful |
Free text
Release 8 — 3 months, dose 2
Symptoms: Excessive bleeding during period.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release